NeuroMetrix to Present at 6th Annual OneMedForum San Francisco 2013

  NeuroMetrix to Present at 6th Annual OneMedForum San Francisco 2013

OneMedForum San Francisco 2013

Business Wire

WALTHAM, Mass. -- January 2, 2013

NeuroMetrix, Inc. (Nasdaq: NURO),, a medical device
company focused on the diagnosis and treatment of the neurological
complications of diabetes, today announced that Shai N. Gozani M.D., Ph.D.,
President and Chief Executive Officer, is scheduled to speak at the 6^th
Annual OneMedForum at the Sir Frances Drake Hotel, San Francisco, CA on
January 7-9, 2013. Dr. Gozani intends to provide an update on the Company’s
business activities and on its diabetes products including
NC-stat^®DPNCheck^™, a diagnostic test for systemic neuropathies such as
diabetic peripheral neuropathy (DPN), and the SENSUS™pain management device
for relief of chronic intractable pain.

NeuroMetrix's presentation is scheduled for Tuesday, January 8, 2013 at 11:40
am (Pacific Standard Time), 2:40 pm (Eastern Standard Time). A live audio
webcast will be available on the investor relations section of the corporate
website - This webcast will be archived after the live

About NeuroMetrix

NeuroMetrixis an innovative medical device company that develops and markets
home use and point-of-care devices, associated consumables, and support
software for the treatment and management of diabetes and its complications.
The company is focused on nerve related complications of diabetes, called
diabetic neuropathies, which affect over 50% of people with diabetes. If left
untreated, diabetic neuropathies trigger foot ulcers that may require
amputation, cause disabling chronic pain, and increase the risk of falling in
the elderly. The annual cost of diabetic neuropathies has been estimated
at$14 billioninthe United States. The company’s products are used by
physicians and other clinicians in retail health settings such as pharmacies,
and by managed care organizations to optimize patient care and reduce
healthcare costs. The company markets the NC-statDPNCheckdevice, which is a
rapid, accurate, and quantitative point-of-care test for diabetic neuropathy.
This product is used to detect diabetic neuropathy at an early stage and to
guide treatment. The company has also begun to market the SENSUS Pain
Management System for treating chronic pain, focusing on physicians managing
patients with painful diabetic neuropathy. The company has additional
therapeutic products in its pipeline. For more information, please visit


NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
Press spacebar to pause and continue. Press esc to stop.